Fundraising FoxArgonautic Ventures — 2026 Investments
2 investments dated 2026 · listed companies and verified rows first · show all
Accipiter Biosciences uses computational protein design to develop de novo, single-agent protein therapies that engage multiple cell-surface receptors at once, functioning as agonists.
AI & Machine LearningBiotechDeep TechSeattle, US
Matthew Bick(Executive Officer, Director, Promoter)inJavier Castellanos(Executive Officer, Director, Promoter)inHector De Jesus Rincon Arano(Executive Officer, Promoter)Heather Redman(Director)Randall Schatzman(Director)William Canestaro(Executive Officer)in
Co-investorsCreative Destruction Lab (CDL)Flying Fish VenturesColumbus Venture PartnersPack VenturesWRF Capital
Aliro provides a full-stack software platform for quantum networking, including simulation, orchestration, and operating system solutions that enable enterprises and government agencies to plan and deploy quantum networks for applications like QPU interconnection and quantum-secured communications.
CybersecurityDeep TechEnterprise SoftwareQuantum ComputingBoston, US
Michael Cubeddu(Co-Founder, CTO, and Board Member)inJim Ricotta(CEO & Chairman)inPrineha Narang(Founder)
Co-investorsArgon VenturesBantam GroupCisco InvestmentsCrosslink CapitalFlybridge Capital PartnersGutbrain Ventures+6 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.